Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Jul 20;25(29):5367-73.
doi: 10.1016/j.vaccine.2007.05.002. Epub 2007 May 22.

A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults

Robert L Atmar  1 , Wendy A Keitel, Thomas R Cate, Flor M Munoz, Fred Ruben, Robert B Couch
Affiliations
Randomized Controlled Trial

A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults

Robert L Atmar et al. Vaccine. .

Abstract

Epidemic influenza occurs annually throughout the world and is accompanied by excess morbidity and mortality. Increasing the antigen content and topical administration of vaccine are two strategies being explored to improve the immune responses to trivalent inactivated influenza vaccine (TIV). We conducted a randomized, double-blind, placebo-controlled trial to compare the immunogenicity and reactogenicity of intramuscular (IM), intranasal (IN), or combined IM and IN administration of a contemporary US vaccine formulation at escalating dosage levels in young healthy adults. Two hundred forty three healthy adults between the ages of 18 and 45 years received 15, 30, or 60mcg of trivalent inactivated influenza vaccine by either IN, IM or both routes, 120mcg of vaccine IM, or placebo IN and IM. All dosages and routes of vaccine administration were well-tolerated. A bad taste and mild nasal discomfort were more likely to be reported when influenza vaccine was administered IN, while arm tenderness was more common after IM administration. Significant increases in geometric mean serum antibody titers in both HAI and Nt assays were seen in all of the groups receiving influenza vaccine for all test antigens (P<or=.025, paired t-test), except for the B HAI antibody titer in the group that received 30mcg IN (P=.055, paired t-test). Postvaccination geometric mean serum antibody titers, the frequency of seroresponses, and the percentage achieving postvaccination serum HAI antibody titers of >or=32 were higher following delivery of the study vaccines by an IM route than by the IN route, but significant increases in serum antibody were seen after IN vaccination. Nasal IgA antibody responses were more common when vaccine was administered IN; and, when the IN dosage was increased, the primary benefit from IN vaccine over IM vaccine appeared to be greater induction of nasal secretory antibody.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency, by vaccine group, of subjects with postvaccination serum HAI antibody titer ≥32 for H1 (A), H3 (B) and B (C) test antigens.
Figure 1
Figure 1
Frequency, by vaccine group, of subjects with postvaccination serum HAI antibody titer ≥32 for H1 (A), H3 (B) and B (C) test antigens.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2006;55:1–42. - PubMed
    1. Barker WH, Mullooly JP. Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths. JAMA. 1980;244:2547–9. - PubMed
    1. Keitel WA, Atmar RL, Cate TR, et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med. 2006;166:1121–7. - PubMed
    1. Keitel WA, Couch RB. Inactivated influenza vaccines. In: Potter CW, editor. Influenza. New York: Elsevier; 2002. pp. 145–77.
    1. Gross PA, Quinnan GV, Jr, Weksler ME, Gaerlan PF, Denning CR. Immunization of elderly people with high doses of influenza vaccine. J Am Geriatr Soc. 1988;36:209–12. - PubMed

Publication types